|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Clin Adv Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes: a challenging disease for patients and physicians
|
Feb 2012
|
J Assoc Physicians India
|
myelodysplastic syndromes (MDS)
|
|
Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry.
|
Feb 2012
|
Biomark Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Immunosuppressive Therapy in Aplastic Anemia.
|
Jan 2012
|
Indian J Pediatr.
|
aplastic anemia
|
|
A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes
|
Jan 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
|
Jan 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.
|
Jan 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
How I treat acquired aplastic anemia
|
Jan 2012
|
Blood
|
aplastic anemia
|
|
Mutations in epigenetic regulators in myelodysplastic syndromes
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
